MAYORANDIL 5 is a prescription cardiovascular medication containing Nicorandil 5 mg, widely used in the management of angina pectoris and other ischemic heart conditions. Nicorandil is a potassium channel activator with nitrate-like properties, which helps in dilating coronary arteries and reducing cardiac workload, thereby improving blood flow to the heart muscle.

Cardiovascular diseases, including angina and ischemic heart disease, are leading causes of morbidity and mortality in India. MAYORANDIL 5 offers a comprehensive and effective therapeutic approach to managing these conditions, improving quality of life and reducing the risk of serious cardiac events. Its dual action mechanism ensures both venous and arterial dilation, making it a preferred option for patients who require long-term management of chronic stable angina.

Uses

MAYORANDIL 5 is prescribed for conditions where enhanced coronary blood flow and reduced cardiac workload are essential:

1. Chronic Stable Angina

MAYORANDIL 5 helps alleviate chest pain caused by reduced blood flow to the heart, improving exercise tolerance and reducing the frequency of angina attacks.

2. Ischemic Heart Disease

By dilating coronary arteries, Nicorandil increases oxygen supply to the myocardium, helping manage symptoms associated with ischemic heart disease.

3. Prevention of Angina Episodes

Regular use of MAYORANDIL 5 reduces the risk of recurrent angina attacks, providing patients with better day-to-day cardiovascular stability.

4. Heart Failure Adjunct Therapy

In some cases, Nicorandil can be used alongside standard heart failure medications to improve cardiac efficiency and relieve symptoms of cardiac stress.

5. Combination Therapy

MAYORANDIL 5 can be safely combined with other anti-anginal medications such as beta-blockers, calcium channel blockers, or nitrates to optimize symptom control.

Benefits

MAYORANDIL 5 offers multiple clinical and patient-centric benefits:

1. Dual Mechanism of Action

• Potassium Channel Activation: Reduces cardiac workload by causing arteriolar dilation.

• Nitrate-Like Effect: Relaxes veins and coronary arteries, improving oxygen delivery to the heart.

This dual action results in reduced angina frequency, improved exercise tolerance, and better overall cardiac performance.

2. Improved Quality of Life

Patients taking MAYORANDIL 5 report fewer chest pain episodes, reduced need for rescue medications, and enhanced ability to perform daily activities.

3. Cardiovascular Protection

By improving coronary blood flow and reducing cardiac oxygen demand, MAYORANDIL 5 lowers the risk of myocardial ischemia and associated complications.

4. Symptom Relief

Regular therapy helps alleviate symptoms of angina, reduce fatigue, and improve physical endurance, contributing to better overall well-being.

5. Compatibility with Other Medications

MAYORANDIL 5 can be used alongside other cardiovascular drugs, providing flexibility in complex treatment regimens for patients with comorbidities such as hypertension or heart failure.

6. Convenient Dosing

The oral tablet form allows for easy administration and adherence to long-term therapy, ensuring sustained symptomatic relief.

Dosage

The dosage of MAYORANDIL 5 should be individualized according to the patient’s condition, severity of angina, and response to therapy.

Recommended Dosage:

• Usual Adult Dose: One tablet (5 mg) once or twice daily

• Route: Oral

• Administration: Take with water, preferably at the same time each day

Important Dosage Considerations:

• Dose may be adjusted depending on clinical response and tolerance

• For elderly patients or those with renal or hepatic impairment, a lower starting dose may be recommended

• Abrupt discontinuation is not generally associated with rebound symptoms, but therapy should follow physician guidance

Regular monitoring of blood pressure, heart rate, and angina frequency is advised to optimize therapy.

Side Effects

MAYORANDIL 5 is generally well tolerated, but some patients may experience side effects:

Common Side Effects:

• Headache, often related to nitrate-like vasodilation

• Flushing or warmth in the face or neck

• Dizziness or lightheadedness

• Nausea or mild gastrointestinal discomfort

Less Common Side Effects:

• Palpitations or rapid heartbeat

• Hypotension in sensitive individuals

• Rare skin or mucosal ulceration

Rare but Serious Side Effects:

• Severe hypotension or fainting

• Severe allergic reactions including rash, swelling, or difficulty breathing

• Rare gastrointestinal or mucosal ulcers requiring medical attention

Patients experiencing persistent, severe, or unusual side effects should contact their healthcare provider immediately.

Precautions and Warning

Certain precautions should be observed for safe and effective use of MAYORANDIL 5:

1. Blood Pressure Monitoring

Patients with hypotension or heart failure should be closely monitored, as Nicorandil may exacerbate low blood pressure in sensitive individuals.

2. Kidney and Liver Function

Dose adjustment may be necessary in patients with renal or hepatic impairment to avoid drug accumulation and adverse effects.

3. Pregnancy and Lactation

MAYORANDIL 5 should only be used during pregnancy or breastfeeding if clearly indicated and under medical supervision.

4. Drug Interactions

Inform your healthcare provider if taking:

• Nitrates or nitrate-containing medications

• Antihypertensives or vasodilators

• Drugs affecting heart rate or blood pressure

5. Lifestyle Measures

Optimal outcomes are achieved with healthy lifestyle practices, including balanced diet, moderate exercise, smoking cessation, and stress management.

Conclusion

MAYORANDIL 5, containing Nicorandil 5 mg, is a clinically proven, safe, and effective therapy for managing chronic stable angina and ischemic heart disease. Its dual mechanism of action ensures improved coronary blood flow, reduced cardiac workload, and decreased frequency of angina attacks, resulting in better exercise tolerance and quality of life for patients.

The medication’s oral tablet form allows for easy administration and long-term adherence, while its compatibility with other cardiovascular drugs provides flexibility for complex treatment regimens. MAYORANDIL 5 is suitable for patients with chronic angina, ischemic heart disease, or those requiring adjunct therapy for heart failure or hypertension.